PC_095 CIN II+ Detection Rates – Does Colposcopic Biopsy Strategy Matters? A multi-Center Analysis

Gabi Haran 1 , Liron Kogan 1,2 , Gadi Ben Shitrit 1 , Zvi Vaknin 3,4 , Avinoam Tzabari 5 ,
Yoav Baruch 1,4,6 1. Assuta Medical Centers, Colposcopy & Cervical pathology Unit, Israel. 2. HaEmek Medical Center, Department of Gynecology, Israel.; 3. Yitzhak Shamir Medical Center, Gynecologic Oncology Unit, Israel.  4. Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Tel Aviv, Israel. 5. Maayanei Hayeshua Medical Center, Department of Gynecology, Israel. 6. Ichilov Medical Center, Department of Gynecology, Israel

PC_086 Digital health intelligence and community mobilization to expand HPV vaccine coverage and cervical cancer screening

R. Annette (1), S. Tércia (2), F. Herla (3), P. Fabiana (1), B. Regina Flavia (1), C. Marcella (4), D.S. Maria Eduarda (5), R. Samila (5)
(1) Grupo Mulheres Do Brasil, Fortaleza, Brésil, (2) Universidade Federal De Minas Gerais, Belo Horizonte, Brésil, (3) Universidade Federal Do Piauí, Fortaleza, Brésil, (4) Harvard Medical School | Mass General Hospital, Estados Unidos Da América, Brésil, (5) Universidade Federal Do Ceará, Fortaleza, Brésil